نتایج جستجو برای: 0 vs 1 and acid treatment 0 vs 2

تعداد نتایج: 17925661  

2018
David Goldblatt Jo Southern Nick J Andrews Polly Burbidge Jo Partington Lucy Roalfe Marta Valente Pinto Vasilli Thalasselis Emma Plested Hayley Richardson Matthew D Snape Elizabeth Miller

BACKGROUND Infants in the UK were first offered a pneumococcal conjugate vaccine (PCV7) in 2006, given at 2 and 4 months of age and a booster dose at 13 months (2 + 1 schedule). A 13-valent vaccine (PCV13) replaced PCV7 in 2010. We aimed to compare the post-booster antibody response in UK infants given a reduced priming schedule of PCV13 (ie, a 1 + 1 schedule) versus the current 2 + 1 schedule ...

Journal: :Journal of animal science 2010
J A Atkins M F Smith K J Wells T W Geary

There is large variation in dominant follicle diameter at the time of GnRH-induced ovulation in the CO-Synch protocol [a first GnRH injection on d -9 (GnRH1), followed by PGF(2alpha) on d -2, and a second GnRH injection (GnRH2) with timed AI on d 0], and the reason for the presence of small dominant follicles at GnRH2 is not known. Our hypothesis was that ovulatory response to GnRH1 and progest...

Journal: :The Lancet. Oncology 2013
Jesus San Miguel Katja Weisel Philippe Moreau Martha Lacy Kevin Song Michel Delforge Lionel Karlin Hartmut Goldschmidt Anne Banos Albert Oriol Adrian Alegre Christine Chen Michele Cavo Laurent Garderet Valentina Ivanova Joaquin Martinez-Lopez Andrew Belch Antonio Palumbo Stephen Schey Pieter Sonneveld Xin Yu Lars Sternas Christian Jacques Mohamed Zaki Meletios Dimopoulos

BACKGROUND Few effective treatments exist for patients with refractory or relapsed and refractory multiple myeloma not responding to treatment with bortezomib and lenalidomide. Pomalidomide alone has shown limited efficacy in patients with relapsed multiple myeloma, but synergistic effects have been noted when combined with dexamethasone. We compared the efficacy and safety of pomalidomide plus...

2013
D. Mazza C. E. Martino L. Micheli Giorgi P. Correale

Background: TSPP is a 27 poly-epitope peptide anti-cancer vaccine which includes the amino acidic sequences of 3 known CTL-epitopes with HLA-A(*)02.01 binding motifs, contained in the thymidylate synthase (TS), a tumourassociated enzyme antigen critical for DNA synthesis and repair. The immunological and antitumor activity of TSPP has already been tested in preclinical studies, whose results of...

2014
Andressa Guariento Marco F Silva Priscilla SF Tassetano Sílvia M Rocha Lúcia M Campos Marcelo Valente Clovis A Silva

OBJECTIVE To evaluate liver and spleen dimensions in childhood-onset systemic lupus erythematosus (c-SLE) patients and healthy controls. METHODS 30 c-SLE patients and 30 healthy control volunteers underwent abdominal ultrasound. The following two liver measurements were performed in left hepatic lobe: craniocaudal and anteroposterior and three in right hepatic lobe (RHL): posterior craniocaud...

Journal: :Anesthesiology 2006
Manzo Suzuki Syuji Haraguti Kikuzo Sugimoto Takehiko Kikutani Yoichi Shimada Atsuhiro Sakamoto

BACKGROUND Ketamine potentiates intravenous or epidural morphine analgesia. The authors hypothesized that very-low-dose ketamine infusion reduces acute and long-term postthoracotomy pain. METHODS Forty-nine patients scheduled to undergo open thoracotomy were randomly assigned to receive one of two anesthesia regimens: continuous epidural infusion of ropivacaine and morphine, along with intrav...

Journal: :The Lancet. Oncology 2012
Karim Fizazi Howard I Scher Arturo Molina Christopher J Logothetis Kim N Chi Robert J Jones John N Staffurth Scott North Nicholas J Vogelzang Fred Saad Paul Mainwaring Stephen Harland Oscar B Goodman Cora N Sternberg Jin Hui Li Thian Kheoh Christopher M Haqq Johann S de Bono

BACKGROUND Abiraterone acetate improved overall survival in metastatic castration-resistant prostate cancer at a preplanned interim analysis of the COU-AA-301 double-blind, placebo-controlled phase 3 study. Here, we present the final analysis of the study before crossover from placebo to abiraterone acetate (after 775 of the prespecified 797 death events). METHODS Between May 8, 2008, and Jul...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013
Takaya Maruyama Takao Fujisawa Masataka Okuno Hirokazu Toyoshima Kiyoyuki Tsutsui Hikaru Maeda Hisamichi Yuda Masamichi Yoshida Hiroyasu Kobayashi Osamu Taguchi Esteban C Gabazza Yoshiyuki Takei Naoyuki Miyashita Toshiaki Ihara Veronica Brito Michael S Niederman

BACKGROUND Optimal empiric therapy for hospitalized patients with healthcare-associated pneumonia (HCAP) is uncertain. METHODS We prospectively applied a therapeutic algorithm, based on the presence of risk factors for multidrug-resistant (MDR) pathogens in a multicenter cohort study of 445 pneumonia patients, including both community-acquired pneumonia (CAP; n = 124) and HCAP (n = 321). RE...

Journal: :The British journal of dermatology 2012
T Dirschka P Radny R Dominicus H Mensing H Brüning L Jenne L Karl M Sebastian C Oster-Schmidt W Klövekorn U Reinhold M Tanner D Gröne M Deichmann M Simon F Hübinger G Hofbauer G Krähn-Senftleben F Borrosch K Reich C Berking P Wolf P Lehmann M Moers-Carpi H Hönigsmann K Wernicke-Panten C Helwig M Foguet B Schmitz H Lübbert R-M Szeimies

BACKGROUND Photodynamic therapy (PDT) with 5-aminolaevulinic acid (ALA) or its methylester [methyl-5-aminolaevulinate (MAL) or 5-amino-4-oxopentanoate] was recently ranked as first-line therapy for the treatment of actinic keratosis (AK) and is an accepted therapeutic option for the treatment of neoplastic skin diseases. BF-200 ALA (Biofrontera Bioscience GmbH, Leverkusen, Germany) is a gel for...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید